Medicare Part B Premium Drops as a Result of Alzheimer’s Drug Reverse Trend
Due to a setback for Biogen Inc.’s Alzheimer’s disease medication, which drew strong payment limits due to concerns about its safety and effectiveness, Medicare Part […]
Due to a setback for Biogen Inc.’s Alzheimer’s disease medication, which drew strong payment limits due to concerns about its safety and effectiveness, Medicare Part […]